Key result
Thrombolytic therapy for DVT significantly increased early vein patency and major hemorrhage risk compared to anticoagulation, with unproven benefit for reducing post thrombotic syndrome risk.
Why the study?
Does thrombolytic therapy improve vein patency and reduce post thrombotic syndrome in patients with deep vein thrombosis?
Population
Patients with Deep Vein Thrombosis (DVT)
Comparison
Thrombolytic therapy in addition to standard… vs Standard anticoagulation
Design
Meta-analysis
Loading...
Thrombolysis for DVT raises major bleeding without proven PTS prevention; confirms anticoagulation alone as preferred initial therapy.
Systematic Review
Does thrombolytic therapy improve vein patency and reduce post thrombotic syndrome in patients with deep vein thrombosis?
Thrombolytic therapy for DVT improves early vein patency but significantly increases major hemorrhage without proven benefit for preventing post-thrombotic syndrome.
A 2001 study conducted a systematic review in Deep Vein Thrombosis. Thrombolytic therapy vs. Standard anticoagulation was evaluated on Major hemorrhage, vein patency, and post thrombotic syndrome risk. Thrombolytic therapy for DVT significantly increased early vein patency and major hemorrhage risk compared to anticoagulation, with unproven benefit for reducing post thrombotic syndrome risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: